By preventing the growth of HCC and reducing the expression of syndecan-2, MMP-2, MMP-13, and TIMP-2 in rat HCC liver tissue, SSD was also utilized to treat chronic liver disease. This evidence concerns the gene MMP13 and hepatocellular carcinoma.